Answers are grounded in this paper and cite their sources.
This review compiles analytical techniques for determining metoclopramide in pharmaceutical formulations, suggesting implications for quality control.
Metoclopramide (MCP) is a commonly prescribed prokinetic and antiemetic agent used to manage gastrointestinal motility disorders as well as nausea and vomiting. Given its extensive clinical use and the risk of dose-related adverse effects, reliable quantitative determination of MCP in pharmaceutical formulations and biological matrices is crucial for quality control, pharmacokinetic evaluation, and therapeutic monitoring. This review compiles English-language studies published over the past 25 years, retrieved from major scientific databases including Scopus, Web of Science, ScienceDirect, Google Scholar, and PubMed. It provides a critical overview of analytical techniques applied to MCP determination, focusing on chromatographic, spectrometric, and electroanalytical methods. High-performance liquid chromatography (HPLC) remains the most widely used approach because of its robustness, accuracy, and suitability for diverse sample matrices. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) offers superior sensitivity, achieving detection limits in the pg-ng/mL range, and is particularly valuable for advanced bioanalytical studies. Although less sensitive, HPLC-UV methods are still favored for routine pharmaceutical quality control due to their simplicity and cost-effectiveness. Spectrometric and electrochemical techniques, especially those employing nanostructured electrodes, present promising alternatives. Nonetheless, challenges such as MCP instability, matrix interferences, and cost-performance trade-offs remain, highlighting the need for robust, affordable, and portable analytical strategies.
No takes yet. Share an insight, caveat, or question.
Barzani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: